16-OH-E1 Test

16 hydroxy estrone is produced when estrone is metabolized through the 16 hydroxylation pathway. Unlike other estrogen metabolites, this compound binds estrogen receptors strongly and irreversibly, meaning it activates estrogen signaling for a longer duration. As a result, it has potent proliferative effects on estrogen sensitive tissues such as the breast and uterus. Elevated levels are commonly associated with estrogen dominance symptoms including heavy periods, breast tenderness, fibroids, and fluid retention. This pathway is often upregulated in the setting of insulin resistance, inflammation, and excess adipose tissue. Lower levels may reflect reduced estrogen signaling, menopause, or preferential shunting toward less stimulatory pathways. Interpretation is most meaningful when viewed in relation to total estrogen and 2 hydroxy metabolites.